Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A middle-aged adult male with a mild form of
tyrosinemia II
(
Richner-Hanhart syndrome
) is described. Treatment with a low-tyrosine diet caused a fall in plasma tyrosine and clearing of the hyperkeratosis of the soles. Liver biopsy of this patient revealed low but measurable levels of cytoplasmic tyrosine aminotransferase and elevated levels of the mitochondrial tyrosine-metabolizing enzyme
aspartate aminotransferase
. It is hypothesized that these enzymes have been induced in sufficient amounts to account for the mild clinical course.
...
PMID:Hepatic enzymes of tyrosine metabolism in tyrosinemia II. 4 76
Mink pseudodistemper, a recessive disease associated with high blood tyrosine levels, is an animal analogue of the human inborn error of metabolism,
tyrosinemia II
. Affected mink and man have eye and skin lesions. Affected mink have no hepatic tyrosine aminotransferase (TAT) activity, as measured immunologically and biochemically. Hepatic mitochondrial
aspartate aminotransferase
is increased to 188% of control. This new genetic animal model of TAT deficiency should allow new studies of tyrosine metabolism.
...
PMID:Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II. 611 79